Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

50.01
Delayed Data
As of 4:03pm ET
 -1.36 / -2.65%
Today’s Change
49.51
Today|||52-Week Range
72.31
-23.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Operating ActivitiesNet Income / Starting Line541.3M140.9M502.5M633.6M
 
 
 
 
 
Depreciation327.3M330.6M339.1M305.3M
 
 
 
 
 
Total Other Cash Flow105.2M883.6M188.5M293.3M
 
 
 
 
 
Funds From Operations758.3M1.7B1.4B1.2B
 
 
 
 
 
Funds From/For Other Operating Expenses-733.8M489.0M-267.7M-196.2M
 
 
 
 
 
Net Cash Flow - Operating Activities1.5B1.2B1.6B1.4B
 
 
 
 
 
 
InvestingCapital Expenditures-171.7M-178.4M-250.2M-172.2M
 
 
 
 
 
Fixed Asset Disposal345.7M83.9M18.2M2.0M
 
 
 
 
 
Net Assets From Acquisitions -3.2B-127.3M-19.2M-2.2B
 
 
 
 
 
Other Investing - Uses-1.8B-46.7M-64.4M-29.0M
 
 
 
 
 
Other Investing - Sources-1.9M0.000.0018.0M
 
 
 
Net Cash Flow Investing-4.8B-268.4M-315.6M-2.4B
 
 
 
 
 
 
FinancingShort Term Borrowings2.3B-799.4M-1.5B38.0M
 
 
 
 
 
Long Term Borrowings92.8M56.6M-39.7M--
 
 
 
 
Long Term Debt Reduction-1.0B-72.9M-54.7M-44.0M
 
 
 
 
 
Net Proceeds Stock Sale96.2M87.3M6.6B671.6M
 
 
 
 
 
Common Preferred Redeemed-18.6M-11.4M-1.9M0.00
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-291.5M-300.6M-293.6M-367.3M
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing104.8M13.9M14.7M31.0M
 
 
 
 
 
Net Cash Flow - Financing1.1B-1.1B4.7B267.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash18.9M-7.9M-19.2M-208.2M
 
 
 
 
 
 
Net Change In Cash-2.2B-161.4M6.0B-774.7M